Solutions
Company
Resources
Publications
Careers
Contact us
Skip to content
New and Noteworthy
Prostate cancer
Topics
Prostate cancer
Publications
Real-world evidence
Treatment patterns
Drug discovery
Genitourinary cancer
Urothelial cell carcinoma
Health equity
Methodology
Metastatic breast cancer
Colorectal cancer
Non-small cell lung cancer
Comparative effectiveness
Content type
Publication summary
Video
Press releases
Case study
Webinar
Clear
Apply filter
Showing 9 of
0
results
Flatiron Health attends the 2026 American Society of Genitourinary Cancers Symposium to answer oncology's most critical questions
Press releases
Urothelial cell carcinoma
Prostate cancer
Persistent gaps in BRCA mutation testing among mCRPC patients: Insights from US cancer practices (2018–2024)
ASCO GU
Publication summary
Publications
Prostate cancer
Treatment patterns and survival outcomes among lutetium 177-experienced patients with metastatic castration-resistant prostate cancer
ASCO GU
Publication summary
Publications
Prostate cancer
Beyond BRCA: Real-world outcomes with poly(ADP-ribose) polymerase inhibitors among patients with metastatic castration-resistant prostate cancer and homologous recombination repair mutations
ASCO GU
Publication summary
Publications
Treatment patterns
Prostate cancer
Flatiron launches first-of-its-kind AI-powered global prostate cancer datasets
Real-world evidence
Press releases
Prostate cancer
Introducing the prostate cancer Panoramic dataset
Video
Prostate cancer
Real-world evidence on prostate cancer management in Germany: A retrospective analysis of electronic health records to investigate clinical characteristics, treatment patterns, and survival
DGHO
Publication summary
Publications
Prostate cancer
Real-world insights into prostate cancer management using EHR-derived data from the UK
ISPOR Europe
Publication summary
Publications
Prostate cancer
Assessment of racial/ethnic inequities in uptake of PSMA-PET scans among patients with metastatic prostate cancer in the United States
ASCO Annual Meeting
Health equity
Prostate cancer
View more